Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pendulum swings back over breast screening debate

This article was originally published in Clinica

Executive Summary

The long running debate over the value of mammography for breast cancer screening has swung again in favour of the technique, after an Italian study found that it can actually reduce the need for mastectomy. The findings go against previous suggestions that routine mammography can lead to "overdiagnosis" of the disease, thereby increasing the rates of aggressive treatments (see Clinica No 980, p 19).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067937

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel